HUMASIS CO., LTD.

Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.

205470 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 안양시 동안구 전파로 88 신원비젼타워 114호.502호.504호.604호.604-1호.비03-1호.비03-2호, 안양시
Website:: https://www.humasis.com/en/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HUMASIS CO., LTD. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) medical devices. Since its establishment in 2000, the firm has concentrated on Point-of-Care Testing (POCT) solutions, delivering rapid and accurate diagnostic results. Its product portfolio includes a wide range of immunodiagnostic rapid test kits for the early screening of conditions such as infectious diseases, cardiac markers, and tumor markers. A key aspect of its strategy is the in-house development and production of core bio-materials, such as diagnostic antigens, to ensure the quality and accuracy of its kits. The company also provides compact diagnostic instruments for quantitative analysis. Humasis serves a global market, exporting its products to numerous countries with the goal of empowering individuals through accessible self-health management tools.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HUMASIS CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-08-28 00:00	Legal Proceedings Report [기재정정]소송등의제기ㆍ신청(일정금액이상의청구) (손해배상청구 등)	Korean	21.0 KB
2025-08-14 00:00	Interim Report 반기보고서 (2025.06)	Korean	1.8 MB

Automate Your Workflow. Get a real-time feed of all HUMASIS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HUMASIS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
SoftOx Solutions AS Develops non-toxic, AMR-safe antimicrobials for wound care, disinfection & airway infections.	Norway	SOFTX
Solasia Pharma K.K. In-licenses and commercializes oncology treatments and supportive care products in Asia.	Japan	4597
Sopharma AD Develops, manufactures, and distributes pharmaceuticals and generics in Bulgaria and regional markets.	Bulgaria	SFA
Spago Nanomedical AB Developing nanomedicines for precise cancer diagnosis and targeted radionuclide therapy.	Sweden	SPAGO
Spexis AG Clinical-stage biopharma developing macrocyclic therapeutics for rare diseases and oncology.	Switzerland	SPEX
Sprint Bioscience Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.	Sweden	SPRINT
STADA Arzneimittel AG A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.	Germany	SAZ
Stayble Therapeutics AB Develops an injectable drug for lumbar disc herniation pain as an alternative to surgery.	Sweden	STABL
STCUBE Develops first-in-class immunotherapies targeting BTN1A1 for treatment-resistant cancers.	South Korea	052020
STELLA PHARMA CORPORATION Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.	Japan	4888